tiprankstipranks
Revolution Medicines (RVMD)
NASDAQ:RVMD
Holding RVMD?
Track your performance easily

Revolution Medicines (RVMD) Financial Statements

288 Followers

Revolution Medicines Financial Overview

Revolution Medicines's market cap is currently ―. The company's EPS TTM is $-3.591; its P/E ratio is -15.35; Revolution Medicines is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 742.00K-
Gross Profit---$ 742.00K-
EBIT$ -156.29M$ -133.23M$ -140.86M$ -132.39M$ -123.25M
EBITDA$ -153.42M$ -115.20M$ -138.10M$ -129.53M$ -121.10M
Net Income Common Stockholders$ -156.29M$ -135.14M$ -116.00M$ -161.54M$ -108.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.55B$ 1.59B$ 1.70B$ 1.85B$ 813.20M
Total Assets$ 1.76B$ 1.81B$ 1.91B$ 2.06B$ 984.23M
Total Debt$ 86.71M$ 87.41M$ 88.03M$ 87.94M$ 62.85M
Net Debt$ -1.46B$ -1.50B$ -1.62B$ -1.77B$ -750.35M
Total Liabilities$ 196.69M$ 189.59M$ 182.90M$ 235.51M$ 146.77M
Stockholders Equity$ 1.57B$ 1.61B$ 1.68B$ 1.83B$ 837.46M
Cash Flow-
Free Cash Flow$ -133.94M$ -130.57M$ -163.73M$ -122.88M$ -103.03M
Operating Cash Flow$ -130.42M$ -128.17M$ -160.56M$ -120.56M$ -100.50M
Investing Cash Flow$ -21.47M$ 107.94M$ -247.97M$ -380.40M$ 77.35M
Financing Cash Flow$ 77.29M$ 7.50M$ 810.00K$ 839.35M$ 1.01M
Currency in USD

Revolution Medicines Earnings and Revenue History

Revolution Medicines Debt to Assets

Revolution Medicines Cash Flow

Revolution Medicines Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis